Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells

Circulation Research

Volumn 83, Issue 3, 1998, Pages 305-313

  Koyama, Noriyuki ^a   Kinsella, Michael G ^b   Wight, Thomas N ^b   Hedin, Ulf ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Extracellular matrix; Heparan sulfate; Platelet derived growth factor; Smooth muscle cell

Indexed keywords

CHONDROITIN ABC LYASE; COLLAGEN TYPE 1; FIBRONECTIN; HEPARIN; HEPARIN LYASE; MATRIGEL; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; SYNDECAN;

ANIMAL CELL; ARTICLE; BABOON; CELL MIGRATION; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FILTER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0032504756     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.3.305     Document Type: Article

References (71)

1. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle cell growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
3. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023-32026.
4. Rekhter MD, Gordon D. Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res. 1994;75:410-417.
5. Ueda M, Becker A, Kasayuki N, Kojima A, Morita Y, Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol. 1996;149:831-843.
6. Schattemann GC, Loushin C, Li T, Hart CE. PDGF-A is required for normal murine cardiovascular development. Dev Biol. 1996;176: 133-142.
7. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994;8:1875-1887.
8. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem. 1992;267:22806-22812.
9. Koyama N, Hart CE, Clowes AW. Different functions of platelet-derived growth factor-α and -β receptors for the migration and proliferation of baboon vascular smooth muscle cells. Circ Res. 1994;75:682-691.
10. Yokote K, Mori S, Siegbahn A, Ronnstrand L, Wernstedt C, Heldin C-H, Claesson-Welsh L. Structural determinants in the platelet-derived growth factor α-receptor implicated in modulation of chemotaxis. J Biol Chem. 1996;271:5101-5111.
11. Schor SL. Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog Growth Factor Res. 1994;5:223-248.
12. DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol. 1993;122:729-737.
13. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992;8:365-393.
14. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 1993;7:1023-1030.
15. Noonan DM, Hassell JR. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 1993;43: 53-60.
16. Wight TN, Kinsella MG, Qwarnström EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol. 1992;4: 793-801.
17. David G, Bai X, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with monoclonal antibodies. J Cell Biol. 1992;119:961-975.
18. 14C]glucosamine into glycosaminoglycans of aortic neointima of balloon-injured and cholesterol-fed rabbits in vitro. Atherosclerosis. 1992;95:59-67.
19. Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia. 1993;36:316-322.
20. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
21. Cizmeci-Smith G, Langan E, Youkey J, Showalter LJ, Carey DJ. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:172-180.
22. Cizmeci-Smith G, Stahl RC, Showalter LJ, Carey DJ. Differential expression of transmembrane proteoglycans in vascular smooth muscle cells. J Biol Chem. 1993;268:18740-18747.
23. Glimelius B, Norling B, Westermark B, Wasteson A. Turnover of cell surface associated glycosaminoglycans in cultures of human normal and malignant glial cells. Exp Cell Res. 1978;117:179-189.
24. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
25. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan): a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem. 1992; 267:8544-8557.
26. Kinsella MG, Tsoi CK, Järveläinen HT, Wight TN. Selective expression and processing of biglycan during migration of bovine aortic endothelial cells: the role of endogenous basic fibroblast growth factor. J Biol Chem. 1997;272:318-325.
27. Hynes RO. Molecular biology of fibronectin. Annu Rev Cell Biol. 1985; 1:67-90.
28. Woods A, Couchman JR, Johansson S, Höök M. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J. 1986;5:665-670.
29. Kinsella MG, Wight TN. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol. 1986; 102:679-687.
30. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1989;1:27-35.
31. Liebersbach BF, Sanderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem. 1994;269:20013-20019.
32. Kato M, Saunders S, Nguyen H, Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 1995;6:559-576.
33. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272:14713-14720.
34. Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol. 1993;122: 933-940.
35. Noda-Heiny H, Sobel BE. Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor. Am J Physiol. 1995;268: C1195-C1201.
36. Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL, Ledbetter SR. CXC chemokines, connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin-heparan sulfate-degrading enzymes. J Biol Chem. 1995;270:3268-3277.
37. Weiser MCM, Grieshaber SS, Belknap JK, Kinsella MG, Majack RA. Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol. 1996;15:331-340.
38. Weiser MCM, Grieshaber NA, Schwartz PE, Majack RA. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol Biol Cell. 1997;8:999-1011.
39. Mathiak M, Yenisey C, Grant DS, Sharma B, Iozzo RV. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res. 1997;57:2130-2136.
40. Carey DJ, Stahl RC, Cizmeci-Smith G, Asundi VK. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J Cell Biol. 1994;124:161-170.
41. Woods A, Couchman JR. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell. 1994;5:183-192.
42. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J Cell Sci. 1993;106:55-65.
43. Woods A, McCarthy JB, Furcht LT, Couchman JR. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell. 1993;4:605-613.
44. Huebsch JC, McCarthy JB, Diglio CA, Mooradian DL. Endothelial cell interactions with synthetic peptides from the carboxy-terminal heparin-binding domains of fibronectin. Circ Res. 1995;77:43-53.
45. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol. 1992;116:521-531.
46. Koyama N, Seki J, Vergel S, Mattsson EJR, Yednock T, Kovach NL, Harlan JM, Clowes AW. Regulation and function of an activation-dependent epitope of the β1 integrins in vascular cells after balloon injury in baboon arteries and in vitro. Am J Pathol. 1996;148:749-761.
47. Seki J, Koyama N, Kovach NL, Yednock T, Clowes AW, Harlan JM. Regulation of β1-integrin function in cultured human vascular smooth muscle cells. Circ Res. 1996;78:596-605.
48. Janat MF, Argraves WS, Liau G. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor beta 1 and by platelet-derived growth factor-BB. J Cell Physiol. 1992;151:588-595.
49. Clyman RI, Mauray F, Kramer RH. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 1992;200:272-284.
50. Corbett SA, Wilson CL, Schwarzbauer JE. Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. Blood. 1996;88:158-166.
51. Akamatsu H, Ichihara K, Ozono K, Kamiike W, Matsuda H, Sekiguchi K. Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin. Cancer Res. 1996;56:4541-4546.
52. Koda JE, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells. J Biol Chem. 1984;259:11763-11770.
53. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
54. Ellis I, Banyard J, Schor SL. Differential response of fetal and adult fibroblasts to cytokines: cell migration and hyaluronan synthesis. Development. 1997;124:1593-1600.
55. Heldin P, Laurent TC, Heldin CH. Effects of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J. 1989;258: 919-922.
56. Jiang B, Yamamura S, Nelson PR, Mureebe L, Kent KC. Differential effect of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery. 1996;120:427-431.
57. Siegbahn A, Hammacher A, Westermark B, Heldin C-H. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest. 1990; 85:916-920.
58. Hayashi N, Takehara K, Soma Y. Differential chemotactic responses mediated by platelet-derived growth factor alpha- and beta-receptors. Arch Biochem Biophys. 1995;322:423-428.
59. Uren A, Yu JC, Gholami NS, Pierce JH, Heidaran MA. The alpha PDGFR tyrosine kinase mediates locomotion of two different cell types through chemotaxis and chemokinesis. Biochem Biophys Res Commun. 1994;204:628-634.
60. Ferns GAA, Sprugel KH, Seifert RA, Bowen-Pope DF, Kelly JD, Murray M, Raines EW, Ross R. Platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. Growth Factors. 1990;3:315-324.
61. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A. 1992;89:1281-1285.
62. Grako KA, Stallcup WB. Participation of the NG-2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res. 1995;221:231-240.
63. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996;271:505-511.
64. Gallo RL, Povsic TJ, Bernfield M. PR-39, an antimicrobial peptide, induces syndecans, binds a receptor and increases cAMP in mesenchymal cells [abstract]. Mol Biol Cell. 1995;6a:162.
65. Yeaman C, Rapraeger AC. Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol. 1993;122: 941-950.
66. Murry CE, Bartosek T, Giachelli CM, Alpers CE, Schwartz SM. Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Circulation. 1996;93:1095-1106.
67. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp Cell Res. 1992;200:156-167.
68. Leppa S, Mali M, Miettinen HM, Jalkanen M. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A. 1992;89:932-6.
69. Takagi A, Kojima T, Tsuzuki S, Katsumi A, Yamazaki T, Sugiura I, Hamaguchi M, Saito H. Structural organization and promoter activity of the human ryudocan gene. J Biochem. 1996;119:979-984.
70. Hinkes MT, Goldberger OA, Neumann PE, Kokenyesi R, Bernfield M. Organization and promoter activity of the mouse syndecan-1 gene. J Biol Chem. 1993;268:11440-11448.
71. Bingley JA, Campbell JH, Hayward IP, Campbell GR. Inhibition of neointimal formation by natural heparan sulfate proteoglycans of the arterial wall. Ann N Y Acad Sci. 1997;811:238-244.